Monte Carlo investigation of PET [68Ga]Ga-DOTA-TOC activity-administration protocols for consistent image quality

[1]  M. Ljungberg,et al.  Validation of a computational chain from PET Monte Carlo simulations to reconstructed images , 2022, Heliyon.

[2]  Ezgi Ilan,et al.  Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by 68Ga-DOTATOC PET/CT , 2021, EJNMMI Research.

[3]  U. Tateishi,et al.  Image quality and quantification accuracy dependence on patient body mass in 89Zr PET/CT imaging , 2021, EJNMMI Physics.

[4]  R. Wahl,et al.  Prospective Within-Patient Assessment of the Impact of an Unlabeled Octreotide Pre-dose on the Biodistribution and Tumor Uptake of 68Ga DOTATOC as Assessed by Dynamic Whole-body PET in Patients with Neuroendocrine Tumors: Implications for Diagnosis and Therapy , 2021, Molecular Imaging and Biology.

[5]  Bradford D. Henderson,et al.  Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target , 2020, EJNMMI Radiopharmacy and Chemistry.

[6]  T. Brabander,et al.  Standardized image quality for 68Ga-DOTA-TATE PET/CT , 2020, EJNMMI Research.

[7]  R. Bundschuh,et al.  Clinical evaluation of [68Ga]Ga-DATA-TOC in comparison to [68Ga]Ga-DOTA-TOC in patients with neuroendocrine tumours. , 2019, Nuclear medicine and biology.

[8]  Live Eikenes,et al.  Image quality and detectability in Siemens Biograph PET/MRI and PET/CT systems—a phantom study , 2019, EJNMMI Physics.

[9]  D. Prosperi,et al.  Role of Combined [68Ga]Ga-DOTA-SST Analogues and [18F]FDG PET/CT in the Management of GEP-NENs: A Systematic Review , 2019, Journal of clinical medicine.

[10]  Didier Benoit,et al.  CASToR: a generic data organization and processing code framework for multi-modal and multi-dimensional tomographic reconstruction , 2018, Physics in medicine and biology.

[11]  P. Ma,et al.  Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas , 2017, Neoplasia.

[12]  W. Oyen,et al.  Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  K. Hemminki,et al.  The epidemiology of metastases in neuroendocrine tumors , 2016, International journal of cancer.

[14]  Francesco d'Errico,et al.  Optimization of oncological ¹⁸F-FDG PET/CT imaging based on a multiparameter analysis. , 2016, Medical physics.

[15]  Eric J. W. Visser,et al.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  George Loudos,et al.  Investigation of realistic PET simulations incorporating tumor patient's specificity using anthropomorphic models: creation of an oncology database. , 2013, Medical physics.

[17]  R. Boellaard,et al.  Optimized dose regimen for whole-body FDG-PET imaging , 2013, EJNMMI Research.

[18]  W P Segars,et al.  Population of anatomically variable 4D XCAT adult phantoms for imaging research and optimization. , 2013, Medical physics.

[19]  A. Kroiss,et al.  68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  C. Boy,et al.  68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors , 2011, The Journal of Nuclear Medicine.

[21]  M. Schwaiger,et al.  Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours? , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  C. Boy,et al.  68Ga-DOTATOC PET/CT and somatostatin receptor (sst1–sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  W. Segars,et al.  4D XCAT phantom for multimodality imaging research. , 2010, Medical physics.

[24]  M. Uetani,et al.  Comparison of Imaging Protocols for 18F-FDG PET/CT in Overweight Patients: Optimizing Scan Duration Versus Administered Dose , 2009, Journal of Nuclear Medicine.

[25]  I. Buvat,et al.  Partial-Volume Effect in PET Tumor Imaging* , 2007, Journal of Nuclear Medicine.

[26]  Osman Ratib,et al.  Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  D. Visvikis,et al.  GATE: a simulation toolkit for PET and SPECT , 2004, Physics in medicine and biology.

[28]  Osman Ratib,et al.  Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  M. Bergström,et al.  PET in the Diagnosis of Neuroendocrine Tumors , 2004, Annals of the New York Academy of Sciences.

[30]  Gyuseong Cho,et al.  Optimization of dual layer phoswich detector consisting of LSO and LuYAP for small animal PET , 2003, 2003 IEEE Nuclear Science Symposium. Conference Record (IEEE Cat. No.03CH37515).

[31]  D. DuBois,et al.  A formula to estimate the approximate surface area if height and weight be known , 1989 .

[32]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .

[33]  Irène Buvat,et al.  Monte-Carlo simulations of clinically realistic respiratory gated 18F-FDG PET: Application to lesion detectability and volume measurements , 2015, Comput. Methods Programs Biomed..

[34]  R. Bale,et al.  Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT , 2007 .

[35]  Uwe Haberkorn,et al.  Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[36]  A. Rose,et al.  Vision: human and electronic , 1973 .